Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.61
-0.39 (-1.50%)
At close: Mar 2, 2026, 4:00 PM EST
25.33
-0.28 (-1.09%)
Pre-market: Mar 3, 2026, 4:47 AM EST

Evommune Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Evommune stock have an average target of 44.17, with a low estimate of 36 and a high estimate of 65. The average target predicts an increase of 72.47% from the current stock price of 25.61.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $36 $44.17 $42 $65
Change +40.57% +72.47% +64.00% +153.81%

Analyst Ratings

The average analyst rating for Evommune stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '25Jan '26Feb '26
Strong Buy 022
Buy 566
Hold 000
Sell 000
Strong Sell 000
Total 588

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$35$65
Strong Buy Maintains $35$65 +153.81% Feb 10, 2026
Oppenheimer
Oppenheimer
Buy
Initiates
$42
Buy Initiates $42 +64.00% Jan 22, 2026
Raymond James
Raymond James
Strong Buy
Initiates
$40
Strong Buy Initiates $40 +56.19% Jan 8, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$35
Strong Buy Initiates $35 +36.67% Jan 6, 2026
William Blair
William Blair
Buy
Initiates
n/a
Buy Initiates n/a n/a Dec 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
13.26M
from 7.00M
Increased by 89.43%
Revenue Next Year
n/a
from 13.26M
EPS This Year
-3.97
from -45.29
EPS Next Year
-2.77
from -3.97
Fiscal Year FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
5.00M7.00M13.26M--
Revenue Growth
-40.00%89.43%--
EPS
-27.17-45.29-3.97-2.77-3.29
EPS Growth
-----
Forward PE
-----
No. Analysts --10107
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 13.7M n/a
Avg 13.3M n/a
Low 12.7M n/a

Revenue Growth

Revenue Growth 202520262027
High
95.0%
-
Avg
89.4%
-
Low
82.0%
-

EPS Forecast

EPS 202520262027
High -2.60 -2.26
Avg -3.97 -2.77
Low -7.05 -3.28

EPS Growth

EPS Growth 202520262027
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.